Market NewsBioMarin (NASDAQ:BMRN) Gains after Elliott Investment Picks Up Stake2y agoBMRNBioMarin Pharmaceutical (0HNC) Earnings Dates, Call Summary & Reports
Earnings Data
- Report Date
- Nov 02, 2026
- Period Ending
- 2026 (Q3)
- Consensus EPS Forecast
- -0.08
- Last Year’s EPS
- -0.16
After Close (Not Confirmed)
Same Quarter Last Year
BioMarin Pharmaceutical (GB:0HNC) Earnings, Revenues Date & History
The upcoming earnings date is based on a company’s previous reporting, and may be updated when the actual date is announced.
GB:0HNC Q2 2026 Earnings Report
GB:0HNC Upcoming Earnings
BioMarin Pharmaceutical's next earnings date is estimated for November 2, 2026, based on past reporting schedules.
GB:0HNC Earnings History
| Report Date | Fiscal Quarter | Forecast / EPS | Last Year's EPS | EPS YoY Change | Press Release | Slides | Play Transcript |
|---|---|---|---|---|---|---|---|
| Nov 02, 2026 | 2026 (Q3) | -0.08- | -0.16 | ― | ― | ― | ― |
| Aug 06, 2026 | 2026 (Q2) | 0.951.20 | 1.23 | -2.44% (-0.03) | |||
| May 04, 2026 | 2026 (Q1) | 0.690.76 | 0.95 | -20.00% (-0.19) | |||
| Feb 23, 2026 | 2025 (Q4) | 0.17-0.24 | 0.64 | -137.50% (-0.88) | |||
| Oct 27, 2025 | 2025 (Q3) | -0.28-0.16 | 0.55 | -129.09% (-0.71) | |||
| Aug 04, 2025 | 2025 (Q2) | 0.861.23 | 0.55 | 123.64% (+0.68) | |||
| May 01, 2025 | 2025 (Q1) | 0.710.95 | 0.46 | 106.52% (+0.49) | |||
| Feb 19, 2025 | 2024 (Q4) | 0.530.64 | 0.11 | 481.82% (+0.53) | |||
| Oct 29, 2024 | 2024 (Q3) | 0.530.55 | 0.21 | 161.90% (+0.34) | |||
| Aug 05, 2024 | 2024 (Q2) | 0.360.55 | 0.29 | 89.66% (+0.26) |
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous quarter.
Beat Missed
GB:0HNC Earnings-Related Price Changes
| Report Date | Price 1 Day Before | Price 1 Day After | Percentage Change |
|---|---|---|---|
| Aug 06, 2026 | $59.68 | $63.30 | +6.07% |
| May 04, 2026 | $54.97 | $53.20 | -3.22% |
| Feb 23, 2026 | $63.97 | $62.58 | -2.17% |
| Oct 27, 2025 | $53.77 | $53.78 | +0.02% |
Earnings announcements can affect a stock’s price. This table shows the stock's price the day before and the day after its recent earnings reports.
FAQ
When does BioMarin Pharmaceutical (GB:0HNC) report earnings?
BioMarin Pharmaceutical (GB:0HNC) is scheduled to report earning on Nov 02, 2026, After Close (Not Confirmed).
What is BioMarin Pharmaceutical (GB:0HNC) earnings time?
BioMarin Pharmaceutical (GB:0HNC) earnings time is at Nov 02, 2026, After Close (Not Confirmed).
Where can I see when companies are reporting earnings?
You can see which companies are reporting today on our designated earnings calendar.
What companies are reporting earnings today?
You can see a list of the companies which are reporting today on TipRanks earnings calendar.
What is the P/E ratio of BioMarin Pharmaceutical stock?
The P/E ratio of BioMarin Pharmaceutical is N/A.
What is GB:0HNC EPS forecast?
GB:0HNC EPS forecast for the fiscal quarter 2026 (Q3) is -0.08.
BioMarin Pharmaceutical (GB:0HNC) Earnings News
Market NewsBioMarin (NASDAQ:BMRN) Gains after Elliott Investment Picks Up Stake2y agoBMRN